Open an Account
search icon
4
NOTIFICATIONS
Best Algo trading app in India
Bigul

POLY MEDICURE LTD. - 531768 - Intimation Of Bagging Of Award By The Company

 Dear Sir/Madam, Pursuant to Regulation 30 of the SEBI (Listing Obligation and Disclosure Requirements) Regulations, 2015, we are glad to inform that the Company, has won "INDIA MEDICAL DEVICE LEADER OF THE YEAR AWARD" at an event held on 27th April, 2022. The said award was presented by Shri Bhagwanth Khuba, Minister of State for the Ministry of Chemicals and Fertilisers Government of India. The award was received by Mr. Himanshu Baid, Managing Director and Mr. Rishi Baid, Joint Managing Director, on behalf of the Company. Photograph of the award are enclosed. Kindly take a note of the same for your further needful and oblige us.
28-04-2022
Bigul

POLY MEDICURE LTD. - 531768 - Submission Of Certificate Under Regulation 40(9) Of SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015 For The Financial Year Ended On 31St March, 2022

 Dear Sir/Madam, Pursuant to the regulation 40(9) of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, please find attached the certificate issued by practicing Company Secretary for the financial year ended on 31st March, 2022. This is for your information and record.
25-04-2022
Bigul

POLY MEDICURE LTD. - 531768 - Compliance Certificate Pursuant To 7(3) Of SEBI(LODR) Regulations, 2015

 Pursuant to Regulation 7(3) of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, we hereby confirm that activities in relation to both physical and electronic share transfer facility are maintained by the Company's Registrar and Share Transfer Agent, viz., Mas Services Limited, which is a SEBI approved category-I, Registar & Transfer Agent, registered with Securities and Exchange Board of India (SEBI Registration Number : INR000000049).
20-04-2022
Bigul

POLY MEDICURE LTD. - 531768 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation

 Pursuant to Regulation 30 of SEBI(Listing Obligations and Disclosure Requirements) 2015, we wish to inform you that an earnings call will be held on friday, 11th february , 2022 at 4.00 p.m (IST) for discussing the Un-audited Financial Results of the Company for the Quarter ended 31st Decemeber, 2021.
11-02-2022
Bigul

POLY MEDICURE LTD. - 531768 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation

 Pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we wish to inform you that an earnings call will be held on Friday, 11th February, 2022 at 4.00 p.m. (IST) for discussing the Un-audited Financial Results of the Company for the quarter ended 31st December, 2021. Link for joining, Dial in and other details of the call are enclosed herewith. ICICI Securities Limited through its representatives along with Company's officials will coordinate the aforesaid meeting.
09-02-2022

Poly Medicure Consolidated December 2021 Net Sales at Rs 230.28 crore, up 13.15% Y-o-Y

 NULL
31-01-2022
Bigul

POLY MEDICURE LTD. - 531768 - Outcome Of The Board Meeting Of The Company I.E. 31St January, 2022

 Dear Sir/Madam, Pursuant to Regulation 30 and 33 of SEBI (LODR) Regulations, 2015, We are pleased to inform the Stock Exchange that the Board of Directors at their meeting held today i.e. 31st January, 2022, at 232-B, 3RD Floor, Okhla Industrial Estate, Phase-III, New Delhi - 110020, approved the following businesses: a) Unaudited Financial Results (Consolidate & Standalone) alongwith Limited Review Report for the third quarter and nine months ended on 31st December 2021; and b) Any Other businesses. Kindly take a note of the same for your further needful and oblige us. Thanking You,
31-01-2022
Bigul

POLY MEDICURE LTD. - 531768 - Board Meeting Outcome for Outcome Of The Board Meeting Of The Company I.E. 31St January, 2022.

 Dear Sir/Madam, Pursuant to Regulation 30 and 33 of SEBI (LODR) Regulations, 2015, We are pleased to inform the Stock Exchange that the Board of Directors at their meeting held today i.e. 31st January, 2022, at 232-B, 3RD Floor, Okhla Industrial Estate, Phase-III, New Delhi - 110020, approved the following businesses: a) Unaudited Financial Results (Consolidate & Standalone) alongwith Limited Review Report for the third quarter and nine months ended on 31st December 2021; and b) Any Other businesses. Kindly take a note of the same for your further needful and oblige us. Thanking You,
31-01-2022
Bigul

POLY MEDICURE LTD. - 531768 - Statement Of Investor Complaints For The Quarter Ended December 2021

 No.of Investor complaints pending at the beginning of the quarter No.of Investor complaints received during the quarter No.of Investor complaints disposed of during the quarter No.of Investor complaints unresolved at the end of the quarter 0000 Name of the Signatory :- Avinash ChandraDesignation :- Company Secretary and Compliance Officer
20-01-2022
Bigul

POLY MEDICURE LTD. - 531768 - Shareholding for the Period Ended December 31, 2021

 Poly Medicure Ltd has submitted to BSE the Shareholding Pattern for the Period Ended December 31, 2021. For more details, kindly Click here
19-01-2022
Next Page
Close

Let's Open Free Demat Account